The first prospective longitudinal study of outcomes from treatment with direct-acting antivirals (DAAs) suggests the drugs…
Read more
Patients are still at risk of recurrent hepatocellular carcinoma (HCC) after treatment with oral direct-acting antivirals …
Read more
Patients are still at risk of recurrent hepatocellular carcinoma (HCC) after treatment with oral direct-acting antivirals …
Read more
Hepatitis C deaths have declined by 20% in the two years since direct-acting antivirals were added to the PBS, infectious…
Read more
sponsored
Promoted This content has been produced by Gilead     Around 200,000 Australians are still living with chronic…
Read more
GPs are hungry for knowledge about managing five common conditions, an NPS Medicinewise update suggests. A list of…
Read more
PBS listing of direct acting antivirals (DAAs) for hepatitis C has failed to persuade 95% of GPs to prescribe them, a survey…
Read more
Leading Australian gastroenterologists have urged doctors not to be swayed by a “flawed” study that claims new direct-acting…
Read more